{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:48:54Z","timestamp":1786790934650,"version":"build-2736575974"},"reference-count":49,"publisher":"Japanese Society of Hypertension","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1291\/hypres.28.925","type":"journal-article","created":{"date-parts":[[2006,5,30]],"date-time":"2006-05-30T05:55:10Z","timestamp":1148968510000},"page":"925-936","source":"Crossref","is-referenced-by-count":65,"title":["Cardioprotective Mechanisms of Spironolactone Associated with the Angiotensin-Converting Enzyme\/Epidermal Growth Factor Receptor\/Extracellular Signal-Regulated Kinases, NAD(P)H Oxidase\/Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, and Rho-Kinase Pathways in Aldosterone\/Salt-Induced Hypertensive Rats"],"prefix":"10.1291","volume":"28","author":[{"given":"Shigefumi","family":"NAKANO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"YOSHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"OHNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"MATSUOKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mann DL, Deswal A, Bozkurt B, Torre-Amione G: New therapeutics for chronic heart failure. Annu Rev Med<\/i> 2002; 53<\/b>: 59-74.","DOI":"10.1146\/annurev.med.53.082901.104004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Corti R, Burnett JC Jr, Rouleau JL, Ruschitzka F, Luscher TF: Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation<\/i> 2001; 104<\/b>: 1856-1862.","DOI":"10.1161\/hc4001.097191"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Delcayre C, Swynghedauw B: Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol<\/i> 2002; 34<\/b>: 1577-1584.","DOI":"10.1006\/jmcc.2002.2088"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pitt B, Zannad F, Remme WJ, et al<\/i>, Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med<\/i> 1999; 341<\/b>: 709-717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lijnen P, Petrov V: Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol<\/i> 2000; 32<\/b>: 865-879.","DOI":"10.1006\/jmcc.2000.1129"},{"issue":"2","key":"7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1440-1681.1991.tb01417.x","volume":"18","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Harada E, Yoshimura M, Yasue H, et al<\/i>: Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation<\/i> 2001; 104<\/b>: 137-139.","DOI":"10.1161\/01.CIR.104.2.137"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Florian JA, Dorrance A, Webb RC, Watts SW: Mineralocorticoids upregulate arterial contraction to epidermal growth factor. Am J Physiol<\/i> 2001; 281<\/b>: R878-R886.","DOI":"10.1152\/ajpregu.2001.281.3.R878"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dorrance AM, Osborn HL, Grekin R, Webb RC: Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. Am J Physiol<\/i> 2001; 281<\/b>: R944-R950.","DOI":"10.1152\/ajpregu.2001.281.3.R944"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308134200"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fiebeler A, Schmidt F, Muller DN, et al<\/i>: Mineralocorticoid receptor affects AP-1 and nuclear factor- κB activation in angiotensin II-induced cardiac injury. Hypertension<\/i> 2001; 37<\/b>: 787-793.","DOI":"10.1161\/01.HYP.37.2.787"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208851200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Babior BM: NADPH oxidase: an update. Blood<\/i> 1999; 93<\/b>: 1464-1476.","DOI":"10.1182\/blood.V93.5.1464.405a32_1464_1476"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Keaney JF Jr, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA: Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest<\/i> 1996; 98<\/b>: 386-394.","DOI":"10.1172\/JCI118804"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Murase T, Kume N, Kataoka H, et al<\/i>: Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol<\/i> 2000; 20<\/b>: 715-720.","DOI":"10.1161\/01.ATV.20.3.715"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000034738.79310.06"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5304.1308"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Santos MF, McCormack SA, Guo Z, et al<\/i>: Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. J Clin Invest<\/i> 1997; 100<\/b>: 216-225.","DOI":"10.1172\/JCI119515"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kobayashi N, Nakano S, Mita S, et al<\/i>: Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. J Pharmacol Exp Ther<\/i> 2002; 301<\/b>: 459-466.","DOI":"10.1124\/jpet.301.2.459"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00457-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kobayashi N, Mita S, Yoshida K, et al<\/i>: Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 via<\/i> NF-κB induced by oxidative stress. Hypertension<\/i> 2003; 42<\/b>: 1004-1013.","DOI":"10.1161\/01.HYP.0000097547.35570.70"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kobayashi N, Yoshida K, Mita S, et al<\/i>: Betaxolol stimulates eNOS production associated with LOX-1 and VEGF in Dahl salt-sensitive rats. J Hypertens<\/i> 2004; 22<\/b>: 1397-1402.","DOI":"10.1097\/01.hjh.0000125442.28861.44"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kobayashi N, Horinaka S, Mita S, et al<\/i>: Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats. J Hypertens<\/i> 2002; 20<\/b>: 2475-2485.","DOI":"10.1097\/00004872-200212000-00028"},{"issue":"4","key":"25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","volume":"33","author":"ROBERT V","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000118519.66430.22"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT: Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol<\/i> 2002; 161<\/b>: 1773-1781.","DOI":"10.1016\/S0002-9440(10)64454-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL: Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotensin system. Am J Hypertens<\/i> 2004; 17<\/b>: 597-603.","DOI":"10.1016\/S0895-7061(04)00811-8"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.971"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res<\/i> 1991; 69<\/b>: 475-482.","DOI":"10.1161\/01.RES.69.2.475"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H: Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest<\/i> 1994; 94<\/b>: 301-310.","DOI":"10.1172\/JCI117322"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2002.125369"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Flamant M, Tharaux PL, Placier S, et al<\/i>: Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. FASEB J<\/i> 2003; 17<\/b>: 327-329.","DOI":"10.1096\/fj.02-0115fje"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kagiyama S, Qian K, Kagiyama T, Phillips MI: Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy. Hypertension<\/i> 2003; 41<\/b>: 824-829.","DOI":"10.1161\/01.HYP.0000047104.42047.9B"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.765"},{"issue":"1,Pt.2","key":"36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.HYP.35.1.313","volume":"35","author":"YAMAKAWA T","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)00680-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Mukai Y, Shimokawa H, Matoba T, et al<\/i>: Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J<\/i> 2001; 15<\/b>: 1062-1064.","DOI":"10.1096\/fj.00-0735fje"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.213"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.263"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.675"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.877"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.67"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.599"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01178-X"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Hara K, Kobayashi N, Watanabe S, Tsubokou Y, Matsuoka H: Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens<\/i> 2001; 14<\/b>: 321-330.","DOI":"10.1016\/S0895-7061(00)01283-8"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kobayashi N, Hara K, Tojo A, et al<\/i>: Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCε-MAPK-p90RSK, and Rho-kinase pathway. Hypertension<\/i> 2005; 45<\/b>: 538-544.","DOI":"10.1161\/01.HYP.0000157408.43807.5a"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Simon G, Jaeckel M, Illyes G: Development of structural vascular changes in salt-fed rats. Am J Hypertens<\/i> 2003; 16<\/b>: 488-493.","DOI":"10.1016\/S0895-7061(03)00568-5"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039328.33137.6C"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T03:44:04Z","timestamp":1586922244000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.28.925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.28.925","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}